1 / 47

Malignant Melanoma and CDKN2A

Malignant Melanoma and CDKN2A. Kate Coffin. http://www.liuding.com/blog/uploaded_images/fig8-794407.jpg. Melanoma. Genetics and Environment Skin cancer of melanocytes Pre-existing nevus or new nevus Different areas of skin ABCDE assessment system of skin.

tess
Télécharger la présentation

Malignant Melanoma and CDKN2A

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Malignant Melanoma and CDKN2A Kate Coffin http://www.liuding.com/blog/uploaded_images/fig8-794407.jpg

  2. Melanoma Genetics and Environment Skin cancer of melanocytes Pre-existing nevus or new nevus Different areas of skin ABCDE assessment system of skin http://www.aad.org/skin-conditions/dermatology-a-to-z/melanoma/signs-symptoms/melanoma-signs-and-symptoms

  3. Dangers of Melanoma Leading cause of death due to skin disease 2012 estimates in US 76,250 new cases 9,180 deaths National Cancer Institute http://www.cancer.gov/cancertopics/types/melanoma http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/snapshots

  4. Metastasis Spreading to other areas of skin and other tissues 14% 5 year survival rate Miller, A et al. (2006). Melanoma. The New England Journal of Medicine. 355(1), 51-65. PMID:16822996

  5. CDKN2A Cyclin-dependent kinase inhibitor 2A Inhibits CDK4 Tumor Suppressor >30 germline mutations http://en.wikipedia.org/wiki/File:Protein_CDKN2A_PDB_1a5e.png

  6. CDKN2A Domains – Ankyrin repeats Pfam SMART Found in archaea, bacteria, eukarya, and poxvirues In other proteins associated with human disease http://smart.embl-heidelberg.de/ http://pfam.sanger.ac.uk/

  7. CDKN2A Gene Ontology Biological Processes - cell cycle arrest - cell cycle checkpoint - induction of apoptosis - negative regulation of cell growth Cellular Components - nucleus - cytoplasm Molecular Functions -cyclin-dependent kinase inhibitor - protein kinase binding http://amigo.geneontology.org/cgi-bin/amigo/go.cgi

  8. CDKN2A Protein Phylogeny http://www.ebi.ac.uk/Tools/msa/clustalw2/

  9. Human CDKN2A Interaction Network http://string-db.org/

  10. Human CDKN2A Interaction Network http://string-db.org/

  11. Human CDKN2A Interaction Network http://string-db.org/

  12. Human CDK4 Interaction Network http://string-db.org/

  13. CDK4 Domains – Protein Kinase Pfam Conserved from E. coli to humans Catalytic component of Serine/Threoninekinases http://pfam.sanger.ac.uk/

  14. CDK4 Gene Ontology Biological Processes - regulation of cell cycle - regulation of cell proliferation - signal transduction Cellular Components - cyclin-dependent protein kinaseholoenzyme complex - transcription factor complex Molecular Functions -cyclin-dependent protein kinase activity - ATP binding http://amigo.geneontology.org/cgi-bin/amigo/go.cgi

  15. Model of CDKN2A and CDK4 CDK4 CDKN2A

  16. Model of CDKN2A and CDK4 CDK4 CDKN2A Regulated Growth http://chungkitblog.files.wordpress.com/2012/01/ellen-family-visual-medium.jpg

  17. Model of CDKN2A and CDK4 CDK4 CDKN2A

  18. Model of CDKN2A and CDK4 CDK4 CDKN2A Unregulated Growth http://upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Melanoma.jpg/250px-Melanoma.jpg

  19. Model of CDKN2A and CDK4 ? CDK4 CDKN2A

  20. Model of CDKN2A and CDK4 ? CDK4 CDKN2A Regulated Growth http://chungkitblog.files.wordpress.com/2012/01/ellen-family-visual-medium.jpg

  21. Question Can I find a compound that mimics CDKN2A by inhibiting CDK4?

  22. Question Can I find a compound that mimics CDKN2A by inhibiting CDK4? Hypothesis If a compound were known to interact with and inhibit CDK4, it could be used as a drug for melanoma

  23. Experiment – Identify Compound http://pubchem.ncbi.nlm.nih.gov/

  24. Results – Identify Compound 2-Methyl-5-[(4-methylphenyl)amino]benzothiazole-4,7-dione Cdk4 Inhibitor III http://pubchem.ncbi.nlm.nih.gov/

  25. Results – Identify Compound http://pubchem.ncbi.nlm.nih.gov/

  26. Question Can I find a compound that mimics CDKN2A by inhibiting CDK4? Hypothesis If a compound were known to interact with and inhibit CDK4, it could be used as a drug for melanoma Hypothesis If Cdk4 were inhibited by Cdk4 Inhibitor III in a Cdkn2a CKO mouse, the tumor cells would not proliferate and metastasize

  27. Why choose a mouse? Skin and vascular systems Previous cancer model Cdkn2a – Cdk4 interaction http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg

  28. Why choose a mouse? Skin and vascular systems Previous cancer model Cdkn2a – Cdk4 interaction https://www.aalaslearninglibrary.org/fileupload_content/Course245/14_Nude_tumor.jpg

  29. Why choose a mouse? Skin and vascular systems Previous cancer model Cdkn2a – Cdk4 interaction http://string-db.org/

  30. Experiment – Treatment Groups 1 Cdkn2a +/+ http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg http://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg

  31. Experiment – Treatment Groups 1 Cdkn2a +/+ 2 Cdkn2a -/- (CKO) http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg http://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg

  32. Experiment – Treatment Groups 1 Cdkn2a +/+ 2 Cdkn2a -/- (CKO) 3 Cdkn2a +/+ & Cdk4 Inhibitor III http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg http://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg

  33. Experiment – Treatment Groups 1 Cdkn2a +/+ Cdkn2a -/- (CKO) 2 3 Cdkn2a +/+ & Cdk4 Inhibitor III 4 Cdkn2a -/- (CKO) & Cdk4 Inhibitor III http://info.criver.com/flex_content_area/images/nude_mouse-2.jpg http://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg

  34. Experiment – Graft Human Melanoma Cdkn2a +/+ Cdkn2a -/- (CKO) 1 2 Cdkn2a +/+ & Cdk4 Inhibitor III Cdkn2a -/- (CKO) & Cdk4 Inhibitor III 3 4 https://www.aalaslearninglibrary.org/fileupload_content/Course245/14_Nude_tumor.jpg http://www.miketiffee.com/uploaded_images/chemoIV-739375.jpg

  35. Data Collection Microarray analysis of Cdkn2a and Cdk4 expression in cells of mice https://commons.wikimedia.org/wiki/File:DNA_microarray.svg

  36. Expected Microarray Results 1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO) 3) Cdkn2a +/+ & Cdk4 Inhibitor III 4) Cdkn2a -/- (CKO) & Cdk4 Inhibitor III Left Well: Cdkn2a Right Well: Cdk4

  37. Expected Microarray Results 1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO) 3) Cdkn2a +/+ & Cdk4 Inhibitor III 4) Cdkn2a -/- (CKO) & Cdk4 Inhibitor III Left Well: Cdkn2a Right Well: Cdk4

  38. Expected Microarray Results 1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO) 3) Cdkn2a +/+ & Cdk4 Inhibitor III 4) Cdkn2a -/- (CKO) & Cdk4 Inhibitor III Left Well: Cdkn2a Right Well: Cdk4

  39. Expected Microarray Results 1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO) 3) Cdkn2a +/+ & Cdk4 Inhibitor III 4) Cdkn2a -/- (CKO) & Cdk4 Inhibitor III Left Well: Cdkn2a Right Well: Cdk4

  40. Expected Microarray Results 1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO) 3) Cdkn2a +/+ & Cdk4 Inhibitor III 4) Cdkn2a -/- (CKO) & Cdk4 Inhibitor III Left Well: Cdkn2a Right Well: Cdk4

  41. Expected Metastasis Results 1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO) 3) Cdkn2a +/+ & Cdk4 Inhibitor III 4) Cdkn2a -/- (CKO) & Cdk4 Inhibitor III

  42. Expected Metastasis Results 1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO) 3) Cdkn2a +/+ & Cdk4 Inhibitor III 4) Cdkn2a -/- (CKO) & Cdk4 Inhibitor III LEAST METASTASIS

  43. Expected Metastasis Results 1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO) MOST METASTASIS 3) Cdkn2a +/+ & Cdk4 Inhibitor III 4) Cdkn2a -/- (CKO) & Cdk4 Inhibitor III LEAST METASTASIS

  44. Expected Metastasis Results 1) Cdkn2a +/+ 2) Cdkn2a -/- (CKO) MODERATE METASTASIS MOST METASTASIS 3) Cdkn2a +/+ & Cdk4 Inhibitor III 4) Cdkn2a -/- (CKO) & Cdk4 Inhibitor III MODERATE METASTASIS LEAST METASTASIS

  45. Conclusion CDK4 Inhibitor III could be used as an antimelanoma drug by mimicking the tumor suppressor function of CDKN2A in patients with CDKN2A loss of function mutations

  46. Future Directions Test other modes of drug administration Topical cream vs Intravenous solution Different dosages/times of administration Study other proteins in interaction network Look for other tumor suppressors Study effects of UV exposure on CDKN2A How does SPF affect this interaction? Look for compounds in other mutated melanoma pathways

  47. Questions? http://www.liuding.com/blog/uploaded_images/fig8-794407.jpg

More Related